Answers are grounded in this paper and cite their sources.
Using a combined approach of NGS and exon-level aCGH, testing identified a genetic etiology in 15.4% of patients in this cohort and revealed the age at molecular diagnosis for patients. Our study highlights both high- and low-yield genes associated with epilepsy and neurodevelopmental disorders, indicating which genes may be considered for molecular diagnostic testing.
No takes yet. Share an insight, caveat, or question.
Lindy et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: